Bio-Path Holdings (BPTH)
(Delayed Data from NSDQ)
$4.04 USD
+0.02 (0.50%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $4.12 +0.08 (1.98%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/10/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | -6.40 |
Last EPS Surprise | 5.88% |
ABR | 1.00 |
Earnings ESP
|
NA |
---|---|
Current Year | -20.80 |
Next Year | -15.00 |
EPS (TTM) | -40.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | -4.80 | -20.80 | -15.00 |
# of Estimates | NA | 1 | 1 | 1 |
Most Recent Consensus | NA | -4.80 | -20.80 | -15.00 |
High Estimate | NA | -4.80 | -20.80 | -15.00 |
Low Estimate | NA | -4.80 | -20.80 | -15.00 |
Year ago EPS | -10.60 | -13.20 | -33.63 | -20.80 |
Year over Year Growth Est. | NA | 63.64% | 38.15% | 27.88% |
Agreement - Estimate Revisions
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | 0 | 0 | 0 |
Up Last 30 Days | NA | 0 | 0 | 0 |
Up Last 60 Days | NA | 0 | 0 | 0 |
Down Last 7 Days | NA | 0 | 0 | 0 |
Down Last 30 Days | NA | 1 | 0 | 0 |
Down Last 60 Days | NA | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | -4.80 | -20.80 | -15.00 |
7 Days Ago | NA | -4.80 | -20.80 | -15.00 |
30 Days Ago | -5.40 | -4.80 | -20.80 | -15.00 |
60 Days Ago | -5.40 | -4.80 | -20.80 | -15.00 |
90 Days Ago | -5.40 | -4.80 | -20.80 | -15.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | -4.80 | -20.80 | -15.00 |
Zacks Consensus Estimate | NA | -4.80 | -20.80 | -15.00 |
Earnings ESP | NA | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -6.40 | -10.60 | -13.20 | -10.60 | NA |
Estimate | -6.80 | -10.40 | -9.00 | -9.00 | NA |
Difference | 0.40 | -0.20 | -4.20 | -1.60 | -1.40 |
Surprise | 5.88% | -1.92% | -46.67% | -17.78% | -15.12% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more